Bangalee, A., Hanley, S., & Bangalee, V. (2022). MEDICINE AND THE LAW: Dolutegravir as first-line antiretroviral therapy in South Africa: Beware the one-size-fits-all approach. South African Medical Journal, 112(10), 787-790. https://doi.org/10.7196/SAMJ.2022.v112i10.16596